Cystic Fibrosis Pulmonary Exacerbation

Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis

Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis

Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

Prednisone in Cystic Fibrosis Pulmonary Exacerbations

Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations

Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care

Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients

Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients